DGX - Quest Diagnostics Non-GAAP EPS of $2.04 beats by $0.07 revenue of $2.33B beats by $130M
2023-04-27 06:47:15 ET
- Quest Diagnostics press release ( NYSE: DGX ): Q1 Non-GAAP EPS of $2.04 beats by $0.07 .
- Revenue of $2.33B (-10.7% Y/Y) beats by $130M .
- FY2023 revenue to be between $8.93b to $9.08B vs. consensus of $8.98B; adjusted diluted EPS expected to be between $8.45 and $8.95 vs. consensus of $8.70.
For further details see:
Quest Diagnostics Non-GAAP EPS of $2.04 beats by $0.07, revenue of $2.33B beats by $130M